Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes
NN9490-8153
Phase 1 other active
Quick answer
Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes for Type 2 Diabetes is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Type 2 Diabetes
- Phase
- Phase 1
- Modality
- other
- Status
- active